H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered.

Karen Bloch, MD, MPH, and David Haas, MD, have been appointed interim leaders of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center.

Vanderbilt University Medical Center infectious disease experts advise this is the season to think very wisely about planned get-togethers.

The Vanderbilt Antimicrobial Stewardship Program recently expanded to the outpatient realm to provide more support for providers to optimize antibiotic use and delivery in the clinic setting.

A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples.

Celestine Wanjalla, MD, PhD, assistant professor of Medicine in the Division of Infectious Diseases, is among 17 recipients of the Doris Duke Charitable Foundation 2021 Clinical Scientist Development Award.

Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.